Allometric growth of ducts in the mammary glands (MGs) is widely held to be estrogen dependent. We previously discovered that the dietary fatty acid trans-10, cis-12 conjugated linoleic acid (CLA) stimulates estrogen-independent allometric growth and terminal end bud formation in ovariectomized mice. Given the similar phenotype induced by estrogen and CLA, we investigated the shared and/or divergent mechanisms underlying these changes. We confirmed MG growth induced by CLA is temporally distinct from that elicited by estrogen. We then used RNA sequencing to compare the transcriptome of the MG during similar proliferative and morphological states. Both estrogen and CLA affected the genes involved in proliferation. The transcriptome for estrogentreated mice included canonical estrogen-induced genes, including Pgr, Areg, and Foxa1. In contrast, their expression was unchanged by CLA. However, CLA, but not estrogen, altered expression of a unique set of inflammation-associated genes, consistent with stromal changes. This CLA-altered signature included increased expression of epidermal growth factor receptor (EGFR) pathway components, consistent with the demonstration that CLA-induced MG growth is EGFR dependent. Our findings highlight a unique role for diet-induced inflammation that underlies estrogenindependent MG development. (Endocrinology 158: 3126-3139, 2017) T he mammary glands (MGs) transition through a series of developmental states (1), during which time the epithelium varies in its susceptibility to carcinogenesis (2, 3). One particularly sensitive window is puberty (4) when the epithelium undergoes high rates of proliferation and allometric growth (1, 5) to establish the ductal network. In the mouse, multilayered terminal end buds (TEBs) (6) at the ductal termini (7) are the site of coordinated proliferation and apoptosis (8) that are also the primary site of carcinogenesis during puberty (9).
T he mammary glands (MGs) transition through a series of developmental states (1) , during which time the epithelium varies in its susceptibility to carcinogenesis (2, 3) . One particularly sensitive window is puberty (4) when the epithelium undergoes high rates of proliferation and allometric growth (1, 5) to establish the ductal network. In the mouse, multilayered terminal end buds (TEBs) (6) at the ductal termini (7) are the site of coordinated proliferation and apoptosis (8) that are also the primary site of carcinogenesis during puberty (9) .
Mammary growth during puberty is directed by endocrine cues (1) , which are mediated by epithelialstromal cross-talk (10) . The primary initiator of allometric growth has been considered to be estrogen through its actions on epithelial cells (11) , which can be blocked by ovariectomy (5) . In concert with systemic growth hormone (12) , estrogen invokes the stromal production of paracrine insulinlike growth factor-1 (13) (14) (15) . Synthesis of the estrogen-induced epidermal growth factor (EGF) receptor (EGFR) ligand amphiregulin (AREG) is also necessary for ductal development and TEB formation (16) , such that AREG activates stromal EGFR, leading to epithelial mitosis (17) .
The premise that estrogen is essential for allometric growth was challenged by our finding that ovariectomized (OVX) mice fed the fatty acid trans-10, cis-12 conjugated linoleic acid (10,12 CLA) underwent estrogenindependent allometric development and TEB formation (18) . This CLA-stimulated MG growth occurred independently of estrogen and its receptor [estrogen receptor 1 (ESR1)], given that blockade of ESR1 or estrogen biosynthesis failed to abrogate growth (18) . In parallel, activation of PPARG (peroxisome proliferatoractivated receptor-g) by rosiglitazone inhibited CLA-induced mammary growth and ameliorated concomitant metabolic dysregulation (18) , which manifested as delipidated, inflamed adipose tissue (19) and hepatic steatosis (20) . These data pointed to CLA-induced dysregulation of complex stromal-epithelial interactions as part of an estrogen-independent mechanism of mammary ductal elongation and TEB formation. A powerful approach to defining any alternate mechanisms of growth regulation is full-depth RNA sequencing of the transcriptome (21) . We used RNA sequencing to interrogate gene networks in MGs that might be uniquely regulated by CLA relative to those induced by estrogen [RNA sequencing data are available from the National Center for Biotechnology Information Gene Expression Omnibus (22) ; series accession no. GSE94121; https://www.ncbi. nlm.nih.gov/geo/query/acc.cgi?acc=GSE94121]. Our findings revealed that although both estrogen and CLA induce allometric MG growth and TEB formation in OVX mice, each elicits a unique transcriptomic response. Our data implicate local adipose inflammation and its effects on an EGFR-dependent axis as a key component of CLAinduced allometric MG growth. These findings emphasize that not all MG growth is estrogen dependent, which informs mechanisms of estrogen-independent growth, including those in aggressive and difficult-to-treat ESR1 2 breast cancer cases.
Materials and Methods

Animals
The University of California, Davis, institutional animal care and use committee approved all animal experimentation. Balb/ cJ mice (The Jackson Laboratory, Bar Harbor, ME) bred inhouse were housed with a 14-hour light/10-hour dark cycle with ad libitum access to food and water. The mice underwent bilateral ovariectomy under general anesthesia (intraperitoneal ketamine 60 mg/kg and xylazine 10 mg/kg) at 21 to 22 days of age and received postoperative subcutaneous buprenorphine (0.05 mg/kg).
Diets and hormones
Purified diets based on AIN-93G were custom formulated and manufactured by Teklad Diets (Envigo Research Service, Indianapolis, IN). For experiment 1, the control diet and the diet supplemented with 1% 10,12 CLA were given (Table 1) , as recently reported (23) . For experiments 2, 3, and 4, the control and 10,12 CLA diets were given, as reported previously (18) .
For the estrogenization experiments, we administered a dose of estrogen that leads to the levels found during puberty and restores uterine weight in OVX mice (24) . Estrogen (17b-estradiol; Sigma-Aldrich, St. Louis, MO) was administered via the drinking water to simulate dietary intake and avoid the transient spikes that can occur with injection. An ethanolic stock of estrogen (10 mg/ mL) was diluted in water to 200 nM. The control mice received water supplemented with ethanol vehicle (5.45 ppm).
Experimental design
Experiment 1: time course of responses to estrogen and CLA
We first compared the MG growth responses elicited by estrogen and CLA over time. For experiment 1, the mice were fed the control diet immediately after ovariectomy. Seven days later, the mice were assigned to one of three treatments: (1) the control diet without estrogen, (2) the control diet with estrogen orally, or (3) the CLA diet. All treatments began at 20:00 hours, coincident with the start of the dark phase when mice are most active and consume most of their food and water (25) . Cohorts of mice (n = 4 to 9) were subsequently euthanized each day at 8:00 hours at 12, 36, 60, 84, 108, 132, 156, or 180 hours after they began treatment. The mice were administered 5-ethynyl-2 0 -deoxyuridine (100 mL intraperitoneally, 2.5 mg/mL in sterile 
Experiments 2 and 3: sampling for EGFR immunoblotting
For experiment 2, Balb/cJ mice were fed the control diet immediately after ovariectomy and then assigned to the control or 10,12 CLA diet the next day (n = 4/diet). The mice were euthanized 7 days later. Inguinal MGs were flash frozen in liquid nitrogen for protein analysis.
For experiment 3, one inguinal MG was surgically cleared of epithelium (26, 27) at ovariectomy, and the contralateral MG was kept intact. The mice were fed the control diet immediately after ovariectomy and then assigned to either the control or 10,12 CLA diet the next day (n = 4/diet). The mice were maintained on these diets for 21 days. At necropsy, the cleared fat pad (stroma alone) and contralateral intact MG (stroma plus epithelium) were collected for protein analysis.
Experiment 4: blockade of EGFR in vivo
The mice were fed the control diet immediately after ovariectomy and then randomly assigned to receive the control or 10,12 CLA diet the next day. Mice from each group were coadministered daily injections of either dimethyl sulfoxide (30 mL intraperitoneally) or gefitinib (100 mg/kg) for 7 days (n = 4 to 5 per group). At necropsy, the inguinal MGs were collected and prepared as whole mounts for morphometry.
Histological, morphometric, and proliferation analyses of MGs
Whole mounts of MGs were imaged, and their development evaluated as described previously (28, 31) . Epithelial cell proliferation in whole thoracic MGs was localized and quantified, as described previously (28) . Thoracic MGs fixed in 10% formalin were trimmed of excess stroma, embedded in paraffin, sectioned at 4 mm, and stained with hematoxylin and eosin.
RNA extraction, library preparation, RNA sequencing, and data processing and analysis
The MGs for transcriptomic analysis were #4 inguinal MGs collected in experiment 1. Tissue was collected proximal to the teat, up to, but excluding, the supramammary lymph node, providing an epithelium-enriched sample. The samples were flash frozen in liquid nitrogen and stored at 280°C. Total RNA was extracted using QIAzol Lysis Reagent (Qiagen, Redwood City, CA) and treated with DNase-I and eluted from a spin column (Zymo DNA-free RNA Clean and Concentrator-5; Zymo Research Corp., Irvine, CA). The quality of RNA was assessed by agarose gel electrophoresis and Experion automated gel electrophoresis (Bio-Rad, Hercules, CA). A total of 40 samples (n = 5/group) with an RNA quality index of 7.5 to 9.4 (mean, 8.7) were submitted for RNA sequencing library preparation.
The libraries were prepared by the UC Davis DNA Technologies Core using the Stranded Messenger RNA Sequencing Kit for Illumina Platforms with poly-A enrichment (KAPA Biosystems, Wilmington, MA) with 10 cycles of polymerase chain reaction. All 40 libraries were indexed, pooled, and sequenced across four lanes using the Illumina HiSeq 3000 platform (single read 50 bp), with an average of 39,024,536 reads per library.
The libraries were demultiplexed, and FASTQ files for each sample from four lanes were imported to the CLC Genomics Workbench (Qiagen). FASTQ files were concatenated and adapter sequences trimmed before quality control reporting. The ENSEMBL mouse genome (Mus musculus GRCm38.84) and its annotation file were imported to the CLC Genomics Workbench (Qiagen), where reads were mapped to the mouse genome and counted. For each library, 97.89% of the reads could be mapped, with 77.99% mapping uniquely.
Analysis of differential gene expression was performed on raw unique gene reads using the R package DESeq2 (R Foundation, Vienna, Austria) (29) . Data were prefiltered for nonexpressed genes using a cutoff of more than four counts per row. Differential gene expression analysis in experiment 1 was performed within two cohorts-one for the early cohort and one for the late cohort. Samples for and in the early cohort were collected 24 hours before any morphological evidence of a significant growth response to either estrogen or CLA (60 or 108 hours after the start of treatment, respectively). For the late cohort, the samples were collected at the first morphological evidence of a significant growth response (84 hours after the start of estrogen and 132 hours after the start of CLA). Temporally matched control samples were collected from controlfed mice at each of the corresponding time points within a cohort. Within the early and late cohorts, individual contrasts were specified to compare the estrogen-and CLA-exposed MGs with their temporal controls (control estrogen and control CLA , respectively). Genes with an adjusted P value of # 0.05 were considered statistically significant.
Soft cluster analysis of the gene expression profiles across the groups in the early and late cohorts was performed using Mfuzz in R (R Foundation) (30) on normalized unique gene reads (prefiltered for nonexpressed genes) after the rlog transformation was applied using DESeq2. The soft clustering algorithm used by Mfuzz allows a gene to have membership in more than one cluster. Inspection of the cluster overlap plots created directed the selection of eight clusters within the early and late cohorts. The clusters of interest were those in which the control estrogen and control CLA profiles behaved similarly and the profiles for the estrogen-and/or CLA-treated mice either behaved the same or diverged. The core list of genes for each of these clusters was extracted with a membership cutoff of 0.85. The gene lists from these clusters were merged with the differential gene expression data from the DESeq2 output, thereby requiring that the genes in each cluster that were upregulated or downregulated by estrogen or CLA were differentially expressed relative to their cohort-specific control (control estrogen or control CLA , respectively).
The genes in each cluster that overlapped with the DESeq2 differential expression results were imported into Ingenuity Pathway Analysis (IPA; Qiagen). For each cluster, the normalized expression value, log-twofold change, and adjusted P value vs the respective cohort-specific control (control estrogen or control CLA ) were used. Core analysis was run on the top 2000 genes (filtered by the log-fold change, up or down).
Immunoblotting
Homogenates from experiments 2 and 3 were prepared as described previously (18) . The samples were separated using sodium dodecyl sulfate-polyacrylamide gel electrophoresis, transferred to polyvinylidene difluoride, and probed for EGFR (catalog no. 2646, 1:500; Cell Signaling Technology, Danvers, MA) and glyceraldehyde 3-phosphate dehydrogenase (catalog no. G9545, 1:30,000; Sigma-Aldrich, St. Louis, MO).
Statistical analysis
Data were analyzed using the PROC GLM procedure in SAS (SAS Institute, Cary, NC) using one-or two-way analysis of variance. The mass of the MGs and uteri was analyzed using analysis of covariance with the body weight as a covariate. Data were transformed as appropriate. Data were considered statistically significant at P # 0.05.
Results
Experiment 1
Distinct temporality of estrogen-and CLA-stimulated MG growth
We measured the ductal area in four inguinal MGs from mice ingesting estrogen or CLA for 12, 36, 60, 84, 108, 132, 156, or 180 hours. The ductal area increased in response to estrogen after 84 hours ( Fig. 1A and 1B) . In contrast, ductal expansion in response to CLA was only evident after 180 hours (Fig. 1B) . The onset of epithelial proliferation was traced by histochemical detection of 5-ethynyl-2 0 -deoxyuridine in whole thoracic MGs expressed as the ratio of Alexa Fluor 488/4 0 ,6-diamidino-2-phenylindole in ductal termini ( Fig. 2A and 2B ). In both treatments, these termini presented as bulbous TEBs with numerous mitotic figures that were histologically similar ( Fig. 2C and 2D ). Epithelial proliferation was numerically greater after 84 hours of estrogen and was substantially increased after 108 hours (Fig. 2E) . In response to CLA, epithelial proliferation was substantially increased after 132 hours (Fig. 2E ). These measures confirmed that CLA-induced MG growth is temporally uncoupled from that stimulated by estrogen, setting the stage for the transcriptomic analysis outlined in subsequent sections.
Dietary CLA reduces mammary fat pad mass
A hallmark response to dietary 10,12 CLA is adipose lipoatrophy (32) . The mass of the MGs, which is predominantly composed of adipose tissue, was reduced after 108 hours of CLA and then continued to decline numerically at 156 and 180 hours (Fig. 1C) . Given that the comparator phenotype for these studies was estrogen induced, we measured the uterine mass as a readout of the uterotrophic response. The uterine mass was increased after 36 hours of exposure to estrogen (Fig. 1D) . In contrast, consistent with our previous report (18) , there was no uterotrophic effect of the CLA treatment (Fig. 1D) . 
Phenotypic changes to inform RNA sequencing
Given that our overall objective was to contrast the transcriptome underlying estrogen-and CLA-induced MG growth, we used the phenotype as the comparator to identify samples for RNA sequencing, independent of the timing. Thus, we focused on two key phenotypic events common to both treatments. The first event we defined (late cohort) was the point at which significantly increased growth of the ductal network had occurred. For estrogen-treated mice, this occurred at 84 hours after the onset of treatment. For the CLA-fed mice, this occurred at 132 hours ( Figs. 1 and 2 ). The second event (early cohort) was specified to define the transcriptional changes preceding the growth recorded in the late cohort. Therefore, we sampled MGs 24 hours before sampling the late cohort to obtain early cohort samples from the estrogenand CLA-treated mice at 60 hours and 108 hours after treatment initiation, respectively.
Given that our comparative analysis included MGs at different times, an important criterion was to control for temporal changes in the seemingly quiescent glands of OVX mice. For each treatment group (estrogen and CLA within both early and late cohorts), MGs from the control OVX mice were similarly collected at the same times, yielding control estrogen and control CLA samples within the early and late cohorts.
Epithelial cell marker expression
Our samples were enriched for epithelium and also captured changes in the associated stroma. To confirm sample comparability, we evaluated the relative expression of nine mammary epithelial-specific markers (33) and stromal matrix metalloproteases in the control, estrogen-treated, and CLA-treated samples from the early and late cohorts (Fig. 3) . Expression of Krt8 and Krt18 was numerically increased, and Etv5 was significantly increased compared with control CLA in the early and late CLA-treated samples (Fig. 3) . Also, Krt8, Krt18, Etv5, and Epcam were substantially increased relative to the control estrogen group for estrogen-treated samples from the early and late cohorts (Fig. 3) . The changed abundance of these markers confirmed that the small increase in epithelial content induced by estrogen or CLA could be detected by RNA sequencing, and that the extent of change induced by estrogen and CLA was comparable, consistent with the morphological readout (Fig. 1) . In contrast, no difference was found in transcript abundance for Csn1s2a or Lalba between the estrogen-and CLAtreated mice vs their respective temporal controls in either the early or late cohorts (Fig. 3 ). An increase was seen in Csn3 between estrogen and its control in the early phenotype (Fig. 3) . However, Csn3 expression was unchanged by CLA in the early and late cohorts (Fig. 3) . Expression of Mmp3 was unchanged between CLA and its controls but was decreased between estrogen and its controls in the early and late cohorts (Fig. 3) . In contrast, Mmp14 was increased in CLA-treated MGs but remained unchanged in response to estrogen in both cohorts (Fig. 3) . Collectively, these results have confirmed that the epithelial compartment is enriched similarly in estrogenand CLA-treated samples.
Common gene expression changes during estrogenand CLA-induced allometric growth
A differential gene expression analysis was performed separately on the early and late cohorts (four groups per cohort; n = 5 biological replicates per group) by specifying pairwise contrasts for CLA vs control CLA and estrogen vs control estrogen within each cohort. Within the early cohort, 1798 genes were differentially expressed between control estrogen and estrogen, and 8601 genes were differently expressed between CLA and control CLA . For the late cohort, 1496 genes were changed in response to estrogen vs its control, and 9844 genes were differentially expressed in CLA-treated MGs compared with their control. We further parsed the data using soft clustering analysis, extracted genes in the clusters of interest with a membership value of $0.85, and merged those lists with our DESeq2 output, thereby ensuring that all genes subjected to pathway analysis had membership in a specific cluster and were differentially expressed between estrogen or CLA and their respective controls.
Given the phenotypic similarity between estrogen-and CLA-exposed MGs in the early and late cohorts, we expected that a subset of genes would be similarly affected by estrogen and CLA. In the early cohort, an expression cluster was identified in which genes were similarly downregulated by estrogen and CLA and remained unchanged in control estrogen and control CLA (Fig.  4A) . Although Mfuzz failed to identify a cluster in the early cohort in which gene expression was increased by estrogen and CLA relative to control estrogen and control CLA , we expected that this cohort would undoubtedly include premitotic events, prompting us to manually extract genes that were similarly upregulated or downregulated in response to estrogen or CLA, intersected those lists, and generated a heatmap of the top 20 genes (Fig. 4B) . IPA revealed Trp53 and Cdkn1a as predicted upstream regulators that are likely inhibited by estrogen and/or CLA (Supplemental Fig. 1A ). The diseases and disorders represented by these genes included "cancer" and "organismal injuries and abnormalities" and molecular and cellular functions included "cell cycle," "cellular assembly and organization," and "cellular growth and proliferation." The physiological system development and functions characterized by these genes were "organismal survival," "organismal development," and "tissue morphology." These data highlight that core growth-associated pathways are similarly activated within MGs by estrogen and CLA.
We performed the same cluster analysis for estrogenand CLA-induced gene expression changes within the late cohort sharing the phenotype of mitotically active TEBs, which revealed clusters that were similarly upregulated (Fig. 4C) and downregulated (Fig. 4D ) by estrogen and CLA. The top 20 genes that were similarly upregulated and downregulated by estrogen and CLA were then graphically represented as a heatmap (Fig. 4E) . The top upstream regulators were CDKN1A, which was predicted to be inhibited, and CCND1 and PTGER2, which were predicted to be activated (Supplemental Fig. 1B) . The diseases and disorders represented in this gene set included "cancer," "organismal injury and abnormalities," and "reproductive system disease." Molecular and cellular functions included "cell cycle," "cellular assembly and organization," and "DNA replication, recombination, and repair." The physiological system development functions included "organismal survival," "embryonic development," and "reproductive system development and function." Similar to the early cohort, these data indicate that the genes involved in processes such as cell cycle regulation are similarly represented during estrogen-and CLA-stimulated allometric growth. Estrogen stimulates a unique gene expression profile A central hypothesis was that estrogen and CLA induce unique gene expression profiles in the MGs. Cluster analysis identified two clusters for the early cohort in which genes were upregulated or downregulated by estrogen but not CLA (Fig. 5A and 5B). A heatmap of the top upregulated and downregulated genes revealed the estrogen-induced transcription of known targets such as Pgr and Areg (Fig. 5C ), whereas their expression was unchanged by CLA (Fig. 5C ). STAT3 was identified as a primary upstream regulator of the estrogen-induced response (Supplemental Fig. 2A ). The top diseases and disorders included "inflammatory response," "cancer," and "organismal injury and abnormalities." The molecular and cellular functions were "cell death and survival," "cell-cell signaling and interaction," and "molecular transport." The physiological system development and functions included "hematological system development and function," "immune cell trafficking," and "skeletal and muscular system development and function." Similar clustering for estrogen-specific genes was performed for the late cohort ( Fig. 5D and 5E ). Just as for the early cohort, Pgr and Areg were among the top expressed genes that continued to remain unaffected by CLA (Fig. 5F ). In addition to the top 20 genes in this cluster, Foxa1 was also upregulated by estrogen but not CLA (P = 0.04; 1.23 logtwofold increase vs control). Analysis of this gene set using IPA indicated that ESR1 and b-estradiol were the top upstream regulators, as were mifepristone and TGFb1 (Supplemental Fig. 2B ). The top diseases and disorders were "cancer," "organismal injury and abnormalities," and "reproductive system disease" and the molecular and cellular functions included "cellular movement," "cellular growth and proliferation," and "cellular development." The physiological functions included "organismal development," "embryonic development," "nervous system development and function," "tissue development," and "tissue morphology." These findings establish that estrogen stimulates a unique transcriptional program, downstream of STAT3 during the early events of allometric growth and, subsequently, downstream of TGFb1.
CLA modulates expression of a unique estrogen-independent gene subset
Given the estrogen-independent nature of CLA-induced growth, we expected to identify clusters upregulated and downregulated by CLA but not estrogen. Two clusters in Figure 4 . Genes differentially expressed in response to estrogen and CLA reflect cellular proliferation. MG transcriptomes from OVX mice fed either the control or CLA diet plus vehicle or control diet plus estrogen were examined in the early and late cohorts. Early cohort samples were collected 60 or 108 hours after beginning estrogen or CLA treatment, respectively. Late cohort samples were collected 84 or 132 hours after beginning estrogen or CLA treatment, respectively. Matching temporal controls were collected for all time points. Soft cluster analysis revealed genes differentially regulated by estrogen and CLA for the (A) early and (C and D) Late cohorts. (B) For the early cohort, the lists of genes differentially expressed [determined by DESeq2 (29] between either estrogen or CLA and respective controls [control estrogen (Control E ) and Control CLA ] that were similarly upregulated or downregulated were merged. Heatmap of top differentially expressed genes (log-twofold change compared with control) for the early cohort. Green indicates downregulated and red, upregulated, expression. (E) Heatmap of the top upregulated and downregulated genes (logtwofold change compared with control) with membership in the clusters for the late cohort (C and D) were merged with DESeq2 differential expression results. Green indicates downregulated and red, upregulated, expression.
the early cohort met this criterion (Fig. 6A and 6B) . A heatmap of the top 20 CLA-induced upregulated and downregulated genes indicated a unique CLA-dependent signature, with the top 4 upregulated genes involved in immune function (Fig. 6C) . IPA of the top 2000 genes identified CSF2 and lipopolysaccharide (LPS) as top upstream activators and TRP53 and CDKN1A as inhibitors ( Supplemental Fig. 3A) . The top diseases and disorders were "inflammatory response," "cancer," and "organismal injuries and abnormalities." The cellular functions included "cell death and survival," "cellular functions and maintenance," and "cellular growth and proliferation." The physiological functions were "hematological system development and function," "tissue morphology," and "immune cell trafficking." Although some genes specified an "inflammatory response" in response to estrogen (42 genes; Supplemental Fig.  2A) or CLA (558 genes; Supplemental  Fig. 3A) within the early cohort, only one gene (Serpina3) was common between treatments, further emphasizing that estrogen and CLA elicit separate transcriptional responses.
Clusters that were only affected by CLA were also present in the late cohort ( Fig. 6D and 6E) . A heatmap of the top upregulated and downregulated genes again highlighted the increased expression of immune response genes (Fig. 6F) , which was confirmed by IPA. The top upstream regulators that were predicted activators were tumor necrosis factor, interferon-g, and LPS (Supplemental Fig. 3B) , and rosiglitazone and dexamethasone were predicted inhibitors. This gene set reflected "inflammatory response," "infectious diseases," "metabolic disease," and "immunological disease" and functions such as "cellular function and maintenance," "cellular movement," "cell-cell signaling interaction," "cellular development," and "cellular growth and proliferation." The top physiological functions were "hematological system development and function," "tissue morphology," "immune cell trafficking," "lymphoid tissue structure and development," and "organismal development." These results collectively highlight that CLA stimulates local inflammatory pathways of the innate immune system during estrogenindependent allometric growth.
Experiments 2 and 3
Dietary CLA modifies EGFR signaling gene expression
Given the effect of CLA on genes specifying an inflammatory response, we investigated the expression of ADAM17-EGFR signaling components, because they are often upregulated in response to wounding and inflammation (34) and play a crucial role in MG development during puberty (17) . Genes in this pathway were upregulated Figure 5 . Genes differentially regulated by estrogen alone reflect estrogen receptor activation. Mammary transcriptomes for OVX mice fed either the control or CLA diet plus vehicle or the control diet plus estrogen were examined in the early and late cohorts. The early and late cohorts and temporal controls were the same as described in Fig. 4 . Soft cluster analysis using Mfuzz (30) revealed genes that were exclusively regulated by estrogen for the (A and B) early and (D and E) late cohorts. (C and F) Genes with membership in these clusters were merged with the list of differentially expressed genes between estrogen and its control for the early and late cohorts, determined using DESeq2 (29) . Heatmaps of the top upregulated and downregulated genes in response to estrogen [log-twofold change, estrogen vs control estrogen (Control E ) and CLA vs Control CLA ] for the (C) early and (F) late cohort. Green indicates downregulated and red, upregulated, expression.
by dietary CLA in the MGs in both the early and the late cohorts ( Fig. 7A and 7B) . Moreover, EGFR protein expression was increased in the MGs of OVX mice after 7 days of consuming 10,12 CLA (Fig. 8A) . Because EGFR activation occurs in the stroma during MG development (17), we analyzed EGFR protein expression in epithelium-free stroma and intact MGs from OVX mice fed 10,12 CLA for 21 days. Expression of EGFR was specifically increased in the mammary fat pad (Fig. 8B) . Although expression of the EGFR-ligand Areg was not upregulated by CLA, expression of both the AREG sheddase Adam17 (which liberates the membrane-bound form of AREG) and the heparin-binding EGF-like growth factor sheddase Adam12 were upregulated by CLA (Fig. 7A and 7B) . Expression of the ADAM17 inhibitor Timp3 was decreased by CLA ( Fig. 7A and 7B) , and expression of positive regulators of ADAM17, including Rhbdf2 and Plk2, were upregulated ( Fig. 7A and 7B) . Together, these data revealed that CLA differentially regulates key genes in the EGFR signaling axis.
Experiment 4
EGFR antagonism inhibits CLA-stimulated MG growth
Given that CLA upregulates both Egfr messenger RNA and protein expression, we sought to confirm a role for EGFR activation in mediating CLA-stimulated MG growth. Coadministration of the EGFR antagonist gefitinib to OVX mice fed 10,12 CLA inhibited elongation of the MG ducts and TEB formation (P # 0.05; Fig. 8C and 8D ), confirming the essential role of functional EGFR during 10,12 CLA-stimulated estrogen-independent MG growth.
Discussion
A long-held assumption has been that allometric growth of the mammary ducts and TEBs during puberty requires estrogen (35) signaling through its receptor (11) . Through RNA sequencing profiling of CLA-and estrogen-stimulated MG of OVX mice, our findings have established that these similar phenotypic outcomes arise from distinct transcriptional responses.
In both the early and late cohorts, CLA stimulated a pronounced inflammatory response gene signature. Although inflammation in adipose tissue (19, 36, 37) and the associated infiltration of immune cells (38, 39) are established responses to 10,12 CLA, to the best of our knowledge, our data are the first to link a diet-induced inflammatory gene signature with estrogen-independent allometric growth. Inflammation and the associated immune cells fulfill a complicated, often nuanced, role during MG development (40) (41) (42) . The migration of macrophages and eosinophils to TEB is necessary for normal ductal development and TEB formation, and their depletion by g-irradiation blocked this development, which could be restored by immune cell repletion (42) . Thus, mice lacking the macrophage chemoattractant Figure 6 . Genes differentially regulated by CLA alone revealed an inflammatory signature. MG transcriptomes from OVX mice fed either the control or CLA diet plus vehicle or control diet plus estrogen were examined from early and late cohorts and temporal controls, as described in Fig. 4 . Soft cluster analysis using Mfuzz (30) revealed genes differentially regulated by CLA for the (A and B) early and (D and E) late cohorts. (C and F) Genes with membership in these clusters were merged with the list of differentially expressed genes as determined by DESeq2 (29) between CLA and its control for the early and late cohorts. Heatmaps of the top upregulated and downregulated genes by CLA [log-twofold change, estrogen vs control estrogen (Control E ) and CLA vs Control CLA ] for the (C) early and (F) late cohort. Green indicates downregulated and red, upregulated, expression.
CSF1 had impaired TEB development (43) owing to perturbed collagen deposition (44) . In keeping with those findings, Csf1 expression was upregulated in the MGs of CLA-fed mice in the early and late cohorts both but was unaltered by estrogen. Localization of mast cells to the periepithelial stroma is also necessary for ductal development and TEB formation (45) , where 10,12 CLA similarly leads to the recruitment of mast cells proximate to the ducts (39) . Activation of the serine proteases contained in mast cell granules by the peptidase DPP1/ CTSC is required for TEB proliferation and development (45) . In our system, Ctsc expression was upregulated by CLA in the early and late cohorts (0.78 and 1.15 log-twofold change, respectively) but was unchanged by estrogen.
Inflammation is a major response to tissue damage or wounding (46) , in which the transition from an acute inflammatory response to tissue repair and regeneration must occur for proliferation and reepithelialization (47) . We propose that CLA-induced inflammation in the MGs of OVX mice invokes a similar cascade that stimulates epithelial proliferation via an EGFR-dependent mechanism. The MGs are unique, given their adipose-rich stroma (48) , rendering them particularly sensitive to inflammation. We previously reported that coadministration of rosiglitazone blocked the effect of CLA and also ameliorated mammary adipose lipoatrophy (18) . In keeping with those findings, our pathway analyses predicted rosiglitazone as an upstream regulator of the CLA-stimulated transcriptome. Rosiglitazone attenuates inflammation in multiple tissues, including adipose during obesity (49) , supporting a role for increased inflammatory signaling via stromal EGFR activation leading to epithelial proliferation, TEB formation, and ductal elongation.
Expression of Egfr was increased by CLA in the early and late cohorts, as was the EGFR-docking protein Gab2 (50, 51) . Activation of stromal EGFR is required for MG growth during puberty (52, 53) . Expression of the EGFR ligand Hbegf was upregulated by CLA, as was Adam12, the disintegrin and metalloproteinase responsible for shedding mature heparin-binding EGF-like growth factor from its membrane-bound precursor (54, 55) . Transcription of the EGFR ligand Areg is upregulated by estrogen (16), just as it was in our estrogen-exposed early and late cohorts (2.01 and 3.34 log-twofold change, respectively). In stark contrast, Areg expression was unaffected by CLA. However, expression of Adam17, the sheddase that cleaves membrane-bound pro-AREG, was upregulated by CLA in the MGs from the early and late cohorts both, which could potentially and alternatively increase the local availability of AREG.
Lines of evidence have indicated that ADAM17 is required for proteolytic cleavage of pro-AREG (56) (57) (58) . Also, ADAM17 activity is necessary for stromal EGFR activation in the developing MG (17) . Moreover, CLA increased expression of Rhbdf2, which encodes IRHOM2, a crucial regulator of ADAM17 maturation (59) . Expression of IRHOM2 has been implicated as a key component of the innate immune response to LPS (59), linking its expression to an inflammatory cascade. ADAM17 can also be released in exosomes in response to LPS, leading to increased AREG shedding (60) . Also, treatment of gastric mucosal cells with LPS increased EGFR activation in an ADAM17-dependent manner (61) . Taken together, these data and our finding that LPS is a predicted upstream activator of the CLA-induced inflammatory signature in the early and late cohorts support a role for an inflammatory cascade as a stimulator of ADAM17 action. The activity of ADAM17 was also increased in lung epithelium in response to tumor necrosis factor-a and interferon-g (62) , in keeping with our data inferring that interferon-g is an upstream regulator of the CLA-stimulated transcriptome. Similarly, expression of Plk2 was increased by CLA in the early and late cohorts both, concordant with its upregulation during inflammation (63) . These findings align with the demonstration that PLK2 is expressed by mammary epithelial cells (64) and phosphorylates ADAM17 to facilitate the sheddase action of ADAM17 (63) . In parallel, the metalloproteinase inhibitor Timp3, which Figure 7 . EGFR pathway components were differentially regulated by CLA. MG transcriptomes from OVX mice fed either the control or CLA diet plus vehicle or the control diet plus estrogen were examined from early and late cohorts and temporal controls, as described in Fig. 4 blocks ADAM17 activity (65) , was downregulated in the MGs of CLA-fed mice in both cohorts. In contrast, Timp1 expression was upregulated. Expression of TIMPs is spatially constrained in developing MGs, where Timp3 expression is low in TEBs but Timp1 is abundant (17) . TIMP1 does not interfere with ADAM17 action but might prevent the functionality of other disintegrins and metalloproteinases, thereby enabling preferential activity of ADAM17 in TEBs (17) .
Our finding that 10,12 CLA-induced metabolic dysregulation promotes estrogen-independent and EGFRdependent growth of the mammary epithelium could inform our understanding of the factors regulating the growth of aggressive estrogen receptor-negative, progesterone receptor-negative, and triple-negative breast cancer cases. Clear evidence has now shown that obesity and the metabolic syndrome are associated with a greater incidence of these cancer types (66, 67) , which also have increased infiltration by proliferative macrophages and lymphocytes (68) (69) (70) . Similarly, metabolic dysregulation promotes the infiltration of lymphocytes and macrophages into adipose tissue and the MGs (71, 72) , where basal breast cancer cells can promote their differentiation, resulting in the release of various inflammatory cytokines (73) . Given that epithelial-macrophage crosstalk requires ADAM17 activity (74) and that approximately 50% of triple-negative breast cancer cases express the EGFR (75) , our data highlight the potential for EGFR activation in these aggressive cancer subtypes during states such as obesity and metabolic dysregulation.
A further noteworthy outcome from these experiments is, to the best of our knowledge, the first RNA sequencingderived full transcriptome of estrogeninduced proliferation in the MGs of OVX mice. Our data have confirmed many previous findings from various studies probing estrogen-stimulated (76) and puberty-stimulated (33) MG growth, while capitalizing on the power of RNA sequencing to provide a full transcription profile that is not confined by the limitations of earlier array-based approaches (21) . These RNA sequencing data will be a valuable resource for future studies investigating the effects of estrogen on the MG and its transcriptome.
In conclusion, although estrogen and CLA both promote allometric MG growth and TEB development, dietary CLA evokes this phenotype through a distinct estrogenindependent mechanism involving inflammation of the mammary stroma and EGFR activation. Our data highlight the complex interplay between diet, the stromal microenvironment, and epithelial cells in normal MG development and aberrant growth, which might inform the mechanisms of tumor progression, especially for aggressive and difficult to treat estrogen-independent breast cancer subtypes. Differences in mean values are statistically significant; P # 0.05. Control diet plus DMSO, n = 5; 10,12 CLA diet plus DMSO, n = 5; control diet plus gefitinib, n = 5; 10,12 CLA diet plus gefitinib, n = 4.
